| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.245 | 2.516 | 1.852 | 2.769 | 1.524 | 357 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.245 | 2.516 | 1.852 | 2.817 | 1.524 | 357 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 17.205 | 5.011 | 7.047 | 6.469 | 1.973 | 278 | 470 | 526 | 478 | 714 |
| Gross Profit/Loss - EUR | -13.960 | -2.495 | -5.195 | -3.653 | -449 | 78 | -470 | -526 | -478 | -714 |
| Net Profit/Loss - EUR | -14.057 | -2.571 | -5.250 | -3.737 | -495 | 67 | -470 | -526 | -478 | -714 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Anabo Medical Trading S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 306 | 303 | 297 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.155 | 10.561 | 10.569 | 2.332 | 2.204 | 2.221 | 2.150 | 2.321 | 2.388 | 2.205 |
| Inventories | 544 | 1.261 | 1.378 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 11.593 | 9.205 | 9.010 | 2.243 | 2.101 | 2.070 | 2.146 | 2.179 | 2.185 | 2.204 |
| Cash | 19 | 95 | 181 | 90 | 103 | 151 | 4 | 142 | 203 | 1 |
| Shareholders Funds | -21.769 | -24.118 | -28.960 | -32.165 | -32.038 | -31.364 | -31.138 | -31.760 | -32.141 | -32.676 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 34.230 | 34.982 | 39.827 | 34.498 | 34.242 | 33.585 | 33.288 | 34.081 | 34.529 | 34.880 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7912 - 7912" | |||||||||
| CAEN Financial Year |
7912
|
|||||||||
Comments - Anabo Medical Trading S.r.l.